View all Courses
Medical Technology Regulatory Affairs
Master of Science
Course Details
Course Code | SG_SMEDI_M09 |
---|---|
Level | 9 |
Duration | 2.5 years |
Credits | 90 |
Method of Delivery | Online |
Campus Locations | Sligo |
Mode of Delivery | Part Time |
Course Overview
This programme has been designed to meet the growing requirements of Irish Medical Technology companies in filling regulatory and quality assurance roles. The impetus for the development of this specialist programme emerged from industry needs and the content has been developed jointly by NUI Galway and ATU Sligo in conjunction with an industry taskforce comprised of regulatory experts from IMDAs Regulatory and Quality Working Group. The development of the programme is supported by the Irish Medical Devices Association Skillnet and contracting organisation, the Irish Medical Devices Association, the IBEC group that represents the Medical Technology sector.
The course will enable Regulatory Affairs personnel in the Medical Technology industry to understand all current device and diagnostic regulations and to develop the skills necessary to address and prepare for the ever-changing global environment of regulatory affairs. Upon successful completion of the programme, participants receive an MSc award at NFQ Level 9.
Programme objectives:
To produce graduates with the essential breadth and kind of knowledge, skills set and competencies required to function as a regulatory affairs professional in the medical device industry and to be capable of an immediate contribution to regulatory projects and projects with a regulatory element in a medical device company environment.
To ensure that participants have sufficient skills and knowledge to employ appropriate advanced data analysing, synthesising, summarising and research skills in a regulatory environment.
To ensure that participants can effectively communicate and defend scientific data and findings in a variety of forms to regulatory agencies, medical care systems, internal personnel and the public.
To ensure participants have the skills and ability to function within, and adapt to, a changing technical work environment and evolving regulatory frameworks.
To ensure the participants can provide strategic, tactical and operational direction and support for working within regulations to expedite the development and delivery of safe and effective healthcare products to people around the world.
Course outline
The programme consists of a two year part-time Level 9 MSc in Medical Technology Regulatory Affairs (90 credits). The programme shall be made available online using a combination of distance-learning / e-learning technologies and some face to face workshops for an overall blended learning approach. The educational elements will be provided by the ATU Sligo, and NUI Galway staff. Additional lecturing, as required, may be provided by outside specialists and practitioners.The programme consists of 12 modules, each worth 5 ECTS. The programme is delivered over 2-2.5 years. Three modules are delivered per semester. A dissertation (30ECTS) is also carried out over year 1 and year 2.
Please watch our course video to find out more about the course with testimonials from graduate Ida Foley of Teleflex, industry Regulatory experts Robbie Walsh formerly of Boston Scientific and John Kilmartin formerly of Medtronic, Emer Sherry of the Irish Medtech Association and the Atlantic Technological University Sligo and University of Galway course directors.
Who teaches this course?
The programme will be delivered by academic staff from NUI Galway and ATU Sligo, with expertise in Regulatory Affairs, with guest lectures and workshops involving Regulatory Affairs experts from the Medical technology industry sector.
Funding Opportunity
The IMDA skillnet will also support the participation of 15 students undertaking the MSc. degree programme. You can read more about this funding here.
Course Details
Year 1
Semester | Module Details | Credits | Mandatory / Elective |
---|---|---|---|
1 |
Introduction to EU Medical Technology Regulatory AffairsThis module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of the regulatory pathway for placing medical devices on the market in the EU. It explains the legislation applicable and guidelines available to medical device manufacturers. Learning Outcomes 1. Demonstrate they have detailed knowledge and understanding of the new EU regulations i.e. MDR and IVDR, the MDD, AIMD and IVD directives and their context within the EU legislative framework. 2. Source and interpret the applicable New Approach directives (MDD, AIMD and IVD )and the new EU medical device regulations i.e. MDR and IVDR regulating medical device classification within the EU and demonstrate ability to classify devices, including complex combination or novel devices appropriately. 3. Illustrate detailed knowledge and understanding of the role and expectations of the manufacturer, authorized representative, notified body and Competent Authority under the current medical device directives and the MDR and IVDR. 4. Demonstrate they have a knowledge and understanding of conformity assessment procedures under the current medical device directives and the MDR and IVDR. 5. Source and interpret ISO13485 and various other relevant standards and guidance documents e.g. MDCG documents. MEDDEVS, NB-MEDS, GHTF guidance 6. Describe the essential requirements of the medical device directives and the General Safety and Performance Requirements of the MDR and IVDR and how a manufacturer will address and meet each requirement as applicable. 7. Identify appropriate regulatory pathways the submission types involved in the EU regulatory system. 8. Develop strategies to address change control, understand the process of Change Assessment and RA Determinations. Overview of types of Regulatory body notifications and Technical File updates. |
05 | Mandatory |
1 |
Introduction to US Medical Technology Regulatory AffairsThis module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of the regulatory pathway for placing medical devices on the market in the US. It explains the legislation applicable and guidelines available to medical device manufacturers. Learning Outcomes 1. Demonstrate they have detailed knowledge and understanding of the US FDA regulatory process and structure. 2. Source, review, analyse and interpret FDA Regulations, guidance documents, consensus standards, FDA forms . 3. Illustrate an understanding of the steps required to achieve market clearance/approval for a 510(k), PMS, IDE and DeNovo application. 4. Analyse requirements for device listing , establishment registration and post market surveillance 5. Critique and review the current and changing US regulatory environment in response to strategic industry needs and changing global regulatory environment. |
05 | Mandatory |
1 |
Technical Report WritingTechnical Report Writing teaches the participant not only the critical techniques a scientist needs to know when conducting research but also how to write about his or her work. Not only is this relevant for a dissertation and assignments but also for generating formal reports such as clinical evaluation reports. Professionals in industry require the skills to share their work with others, to communicate their learning, their discoveries and their failures, thus improving research and thus benefiting the industry as a whole and more importantly, the patient. Learning Outcomes 1. Diagnose poor technical writing and modify text to demonstrate use of technical writing tools for industry and academic writing 2. Conduct and synthesise an academic literature search relevant to a proposed dissertation or topic and demonstrate competence in the use of Harvard referencing using software where appropriate. 3. Present the research findings in a critically reflective manner which evaluates the research methodologies used, knowledge produced and critically reviews the ethical issues pertaining to the research 4. Formulate and compare methods for data analysis and the presentation of results and compare different methods when presenting different results 5. Present a comprehensive dissertation proposal |
05 | Mandatory |
2 |
Global Medical Technology Regulatory Affairs Part 1This module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of the regulatory pathway for placing medical devices on the market outside of the US and EU, specifically Russia/CiS; Brazil/Latin America; Canada/Australia and New Zealand. It explains the legislation applicable and guidelines available to medical device manufacturers. Learning Outcomes 1. Demonstrate they have detailed knowledge and understanding of the administrative and legislative structure and requirements for medical devices in key global markets to include Russia/CIS; Brazil/Latin America; Canada/Australia and New Zealand. 2. Identify key differences between these regulatory systems and that of the EU and US and outline methodologies to ensure a device can utilize key documentation from EU and US applications in achieving market approval in the above defined jurisdictions. 3. Critique guidances, regulations and legislation currently regulating medical device classification (as applicable ) within these global markets and demonstrate ability to classify devices appropriately. 4. Articulate an understanding of how to define the regulatory pathway for medical devices in these global markets including complex combination or novel devices. 5. Demonstrate they have detailed knowledge and understanding of how to manage change control from a global point of view. 6. Source and interpret reimbursement requirements |
05 | Mandatory |
2 |
Clinical Evaluation ReportingThis module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of how to source, filter and critically appraise relevant clinical literature and to evaluate when a clinical investigation is necessary and the regulatory processes involved in such an evaluation. Learning Outcomes 1. Demonstrate they have detailed knowledge and understanding of the key clinical terms, types of studies, key clinical requirements and associated standards. 4. Demonstrate an ability to source and critically appraise clinical literature and subsequently prepare documentation associated with clinical evaluations and clinical trial applications (as part of a regulatory submissions) 5. Evaluate and assess a medical device to determine what, if any, clinical studies are required based upon a critical review of existing data for comparable medical devices (consider strategy development, trial design and clinical evaluation context) and prepare a CER |
05 | Mandatory |
2 |
Quality Management SystemThis module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of setting up a basic QMS and its implementation. It also aims to provide the students with a thorough understanding of the requirement for a quality management system and how to design this quality system under the CFR 820 or ISO13485 headings. It also aims to provide an overview of compliance assessment in relation to self assessment, external audits, vendor audits and demonstration of ongoing compliance, focusing on Part 11 compliance. The module is broken down as follows: ca 10% Intro/overview of QMS; 75% subsections of CFR 820; 15% Auditing and Part 11 compliance. Learning Outcomes 1. Demonstrate they have a detailed knowledge and understanding of how a medical device is designed and manufactured in line with 20 CFR Part 820 and ISO 13485 2. Demonstrate and understand the basic overall principles of a QMS system 3. Review the individual QMS system and understand in terms of management responsibility, auditing, supplier and vendor auditing, training, records, design control, production controls, statistical process control and corrective and preventative action (CAPA). 4. Understand the role of QMS in terms of regulatory compliance and in achieving market authorisation. 5. Critique and evaluate a QMS system (own organisation/other) |
05 | Mandatory |
Year 2
Semester | Module Details | Credits | Mandatory / Elective |
---|---|---|---|
1 |
EU Medical Technology Regulatory Affairs- AdvancedThis module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of the regulatory pathway for placing medical devices on the market in the EU, the essential requirements of devices and submission types & emerging technologies. Learning Outcomes 1. Demonstrate detailed understanding and knowledge of the new European Medical Device Regulations (MDR) and In vitro diagnostics Regulation (IVDR) 2. Define the regulatory pathway for medical devices and different submission types to get a device to market and to obtain CE approval including ISO13485:2016 3. Understand how to carry out a gap analysis on your regulatory system 4. Demonstrate understanding of notified body and county specific competent authority roles across Europe and the responsibilities of these bodies 5. Critique and evaluate the political, strategic, logistical, manufacturing; landscape effects in Europe on the medical device industry in terms of new legislation; changing standards and guidances;device issues in the media, political changes in Europe. |
05 | Mandatory |
1 |
US Medical Technology Regulatory Affairs AdvancedThis module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of the regulatory pathway for placing medical devices on the market in the US, US Law (FD&C Act) and regulations, the code of federal regulations (CFR), submission types, change control, post market requirements and emerging technologies. Learning Outcomes 1. Demonstrate they have detailed knowledge and understanding of the submission types involved by demonstrating a strategic knowledge of the structure and technical contents of the many different submission types from simple registrations through to 510(k)s, PMAs, IDEs, De Novos etc. and appropriate supplements such as a 30-day supplement or an annual report through a series of appropriate essays, assignments and literature review. 2. Formulate and communicate judgements with regard to best practices and strategic regulatory decision making process for devices and demonstrate ability to interact effectively with FDA agents through systems such as a 513(g) or pre-submission process. 3. Analyse and evaluate data from US FDA MAUDE (Manufacturer and user facility device experience) database. 4. Communicate a detailed knowledge and understanding of how to manage change control for a product destined for US market. |
05 | Mandatory |
1 |
Risk Management, Labelling and PromotionThis module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of the labelling, sale and supply regulatory requirements for medical devices. The module also covers the application of risk management to medical devices. Learning Outcomes 1. Demonstrate they have detailed knowledge and understanding of the content and application of ISO 14971: Medical devices – application of risk management to medical devices & risk management planning and the key components of a risk management file. |
05 | Mandatory |
1 |
Global Medical Technology Regulatory Affairs Part 2This module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of the regulatory pathway for placing medical devices on the market outside of the US and EU, specifically China, Japan, India, East Asia (Taiwan/Korea etc). It explains the legislation applicable and guidelines available to medical device manufacturers. It also addresses emerging technologies. Learning Outcomes 1. Demonstrate they have detailed knowledge and understanding of the administrative and legislative structure and requirements for medical devices in key global markets to include but not limited to China, Japan, India, East Asia (Taiwan/Korea etc) 2. Identify key differences between these regulatory systems and that of the EU and US and outline methodology to ensure a device can utilize key documentation from EU and US applications in achieving market approval in the above defined jurisdictions. 3. Source and interpret guidances,regulations and legislation currently regulating medical device classification within these global markets and demonstrate ability to classify devices appropriately. 4. Illustrate they have detailed knowledge and understanding of how to define the regulatory pathway for medical devices in these global markets including complex combination or novel devices. 5. Communicate how to achieve market clearance/approval for a medical device destined for a global marketplace and how to address post market surveillance requirements once a product is placed on the market. 6. Demonstrate they have detailed knowledge and understanding of the complexities of regulatory strategy within global markets and understand the submission types involved through a series of appropriate assessments covering each geographical region. 7. Formulate and communicate judgements with regard to regulatory issues for devices such as country specific nuances connected with entry/exit from each country and demonstrate ability to interact effectively with appropriate authorities. |
05 | Mandatory |
1 |
Design Assurance, Sterilisation and BiocompatabilityThis module is taken by Level 9 students in Medical Technology Regulatory Affairs. It aims to provide students with a detailed knowledge and understanding of the design assurance process, common sterilization techniques for medical devices, associated standards and validation. It aims to provide a basic understanding of common biocompatibility testing methods and interpretation of results. Learning Outcomes 1. Demonstrate an ability to generate a biocompatibility testing protocol according to standards. 2. Interpret and apply the ISO10993 standards for the evaluation of the biocompatibility of medical devices. 3. Evaluate sterilization methods under various headings to include packaging, products effects, costs etc. 4. Describe current sterilization methods in use detailing rational and system advantages and disadvantages 5. Demonstrate an ability to develop verifiable design inputs and understand the links to riskmanagement activities 6. Interpret and understand test protocols including risk based acceptance criteria, sample sizes and use of appropriate statistical methods |
05 | Mandatory |
1 |
Post Market SurveillanceThis module is taken by Level 9 students in Medical Technology Regulatory Affairs and it aims to provide students with a detailed knowledge and understanding of post market requirements for medical devices. Specifically this module aims to develop the students ability to create and implement a comprehensive post market surveillance plan to collect, evaluate and respond to data on device safety and performance after market approval. Learning Outcomes 1. Demonstrate detailed knowledge and understanding of global PMS requirements with particular emphasis on US and EU. 2. Illustrate detailed knowledge and understanding of post market surveillance requirements and development of a post market surveillance plan that is consistent with the risk associated with the device based on its intended use 3. Understand complaint management and assessment, evaluation and responses to post market data that is risk appropriate 4. Formulate and communicate a post marketing surveillance strategy which meets regulatory requirements 5. Illustrate an understanding of all types of potential field actions including FSCA, CA’s, Advisory notices, recalls including recall letters and types of recalls 6. Understand PMS data analysis including MAUDE and EUDAMED and complaint trend analysis |
05 | Mandatory |
2 |
Medical Technology Regulatory Affairs DissertationThis module is taken by Level 9 students in Medical Technology Regulatory Affairs. This module aims to equip participants with the requisite advanced knowledge, understanding and skills to perform medical device related research using traditional and emerging research designs informed by a critical awareness of developments at the forefront of legislation and practice in the medical device industry. Learning Outcomes 1. Articulate and elaborate an understanding of current thinking on the nature of medical device industry challenges and the value of related research in that context. |
30 | Mandatory |
Recommended Study Hours per week
Examination and Assessment
On-Campus Attendance Requirement
Progression
Upon successful completion of this programme students may be considered for redirection to a structured Doctorate programmes
Download a prospectus
Entry Requirements
Open to students who have obtained a Level 8 primary degree in a science/engineering subject related to the life sciences. Previous or current experience in regulatory affairs (minimum 2 years) may be taken into account in assessing entry qualifications for candidates with relevant Level 7 qualification with appropriate experience.
Candidates who have completed modules in cognate programme areas may also enter the programme and gain exemptions as determined by the Programme Committee in accordance with Institutes guidelines. Cases will be assessed on an individual basis by the Programme Committee. Students applying on the basis of formal qualifications and supplementary accredited prior learning (APL) for core pre-requisites will be required to submit full details and references to the Programme Board for consideration of educational equivalencies. Prior experiential learning will be assessed using guidelines recommended by the Academic Council of ATU Sligo and NUI Galway.
Testimonial
“The MSc Medtech programme has been extremely useful as it is flexible, directly relevant and my fellow colleagues are professionals with extensive medical device experience who are always happy to help or provide a perspective.”
Jacques du Preez (International student) , Director, Psephos Biomedica
Careers
This programme will equip graduates with essential knowledge and skills to work in a Regulatory Affairs environment within the highly successful and growing Irish Medical Technology industry sector.
The Irish Medical Devices Association (IMDA) states that the medical technology sector employs over 25,000 people, with 18 of the worlds top 25 medical technology companies maintaining a base in Ireland and a further 50% of the 300 Medtech companies being indigenous. The sector is expected to continue to grow as stated in December 2014 by the Director of the IMDA Sinead Keogh: ‘IMDA’s latest survey shows that confidence within the sector is improving steadily…. with nearly half of companies more confident now than they were three months ago and nearly half planning to hire new staff.
Regulatory Affairs within the medical technology products sector is a relatively young, multidimensional profession that is international in scope. Operationally, a Regulatory Affairs professional is responsible for assuring that pertinent government obligations, market-driven demands, and evolving scientific conventions are understood and addressed by various stakeholders of the medical and health care system. Given the evolving nature of international regulations, a regulatory affairs professional must continually grow their knowledge and skills to be effective and to advance in their careers.Regulatory professionals at all career and experience levels are involved in activities throughout the product lifecycle, and most are involved to some degree in bridging the gap between regulatory-related functions and organization and business activities.
Further Information
Contact Information
Admissions Office
T: 353 (0) 71 931 8511
E: admissions.sligo@atu.ie
Ms Mary Butler
Atlantic Technological University, Sligo Campus
Prof. Terry Smith
T: 353 91 492 022
Life Sciences